195 related articles for article (PubMed ID: 11193142)
21. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
[TBL] [Abstract][Full Text] [Related]
22. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
24. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
[TBL] [Abstract][Full Text] [Related]
25. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
26. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
[TBL] [Abstract][Full Text] [Related]
27. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
28. Alteration of cortical EEG in mice carrying mutated human APP transgene.
Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
[TBL] [Abstract][Full Text] [Related]
29. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
[TBL] [Abstract][Full Text] [Related]
30. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.
Bondolfi L; Calhoun M; Ermini F; Kuhn HG; Wiederhold KH; Walker L; Staufenbiel M; Jucker M
J Neurosci; 2002 Jan; 22(2):515-22. PubMed ID: 11784797
[TBL] [Abstract][Full Text] [Related]
31. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein.
Yang F; Uéda K; Chen P; Ashe KH; Cole GM
Brain Res; 2000 Jan; 853(2):381-3. PubMed ID: 10640638
[TBL] [Abstract][Full Text] [Related]
32. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
33. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
35. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
36. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
37. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
[TBL] [Abstract][Full Text] [Related]
38. [Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease].
Więdłocha M; Stańczykiewicz B; Jakubik M; Rymaszewska J
Postepy Hig Med Dosw (Online); 2012 Jun; 66():415-30. PubMed ID: 22922141
[TBL] [Abstract][Full Text] [Related]
39. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
[TBL] [Abstract][Full Text] [Related]
40. Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology.
Mohajeri MH; Saini KD; Nitsch RM
J Neural Transm (Vienna); 2004 Mar; 111(3):413-25. PubMed ID: 14991462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]